OTC/SmallCap IRW
MaxsMaking Inc. Reports Fiscal Year 2025 Financial Results
SHANGHAI, March 4, 2026 /PRNewswire/ -- MaxsMaking Inc. (Nasdaq: MAMK) ("MaxsMaking" or the "Company"), a manufacturer of customized consumer goods with a focus on advanced technology and innovation, today announced its financial results for the fiscal year endedOctober 31, 2025. Mr. Xiaozhong L...
2026-03-04 21:00
2124
Locksley Announces High-Grade Antimony Assays at Desert Antimony Mine Confirm Surface Continuity
SAN BERNARDINO, Calif., March 3, 2026 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQX: LKYRF/ADR: LKYLY announced high-grade antimony (Sb) assays received from surface exposure grab sampling, with a peak value of 16.90% Sb confirm continuity of high-grade stibnite mineralization along...
2026-03-03 21:15
2274
Euro Tech Holdings Company Limited Announces Stock Repurchase Program
HONG KONG, March 3, 2026 /PRNewswire/ -- Euro Tech Holdings Company Limited (Nasdaq: CLWT) (the "Company") today announced that its Board of Directors (the "Board") has approved a program to repurchase up to 250,000 shares of its issued and outstanding ordinary shares for an aggregate purchase pr...
2026-03-03 20:00
2983
HIGHWAY HOLDINGS REPORTS FISCAL YEAR 2026 THIRD QUARTER AND NINE MONTH RESULTS
HONG KONG, March 2, 2026 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO) (the "Company" or "Highway Holdings") today reported financial results for its third quarter and nine months fiscal 2026 endedDecember 31, 2025. The Company's results reflect the continued impact of the previously di...
2026-03-02 20:00
3190
LOCKSLEY RESOURCES COMMENCES DRILLING AT ITS HIGH-GRADE DESERT ANTIMONY MINE LOCATED WITHIN THE COMPANY'S MOJAVE PROJECT IN CALIFORNIA
SAN BERNARDINO, Calif., Feb. 23, 2026 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY, OTCQX: LKYRF and LKYLY-ADR) announced the company has commenced diamond drilling at the high-grade Desert Antimony Mine (DAM), located within the company's Mojave Project inCalifornia. The drilling follow...
2026-02-23 21:35
4024
Big Tree Cloud Holdings Limited Announces Implementation of Class A/B Share Structure and 1-for-20 Share Consolidation
SHENZHEN, China, Feb. 19, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company") (NASDAQ: DSY) today announced that it held an extraordinary general meeting onJanuary 30, 2026, at which the shareholders approved the consolidation of every 20 ordinary shares into one ordinary share a...
2026-02-19 21:30
9979
Marvion Inc. Announces Two New Investors, Further Strengthening Capital Base and Advancing Strategic Growth
HONG KONG, Feb. 17, 2026 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) (the "Company" or "Marvion") today announced that onFebruary 2, 2026, the Company entered into Stock Purchase Agreements with two new investors. The transactions were duly disclosed through a Form 8-K filing in accordance with ap...
2026-02-17 21:18
9739
NATURE'S MIRACLE HOLDING INC. PARTICIPATES IN INDOOR AG-CON 2026
ONTARIO, Calif., Feb. 11, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle," "NMHI," or the "Company") (OTCQB: NMHI), a provider of equipment and services for the controlled environment agriculture ("CEA") industry, today announced its participation in Indoor Ag-Con 2026, tak...
2026-02-11 21:30
6391
Locksley Resources' Underground Mapping Reveals Major New Target Boosting High-Grade Antimony Potential at its Mojave Project Desert Antimony Mine
SAN BERNARDINO, Calif., Feb. 10, 2026 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQX: LKYRF/ADR: LKYLY) announced a major new target zone revealed by underground mapping at its Desert Antimony Mine (DAM), part of the company's Mojave Project. This notable finding, the Beefeater Shea...
2026-02-10 23:53
6896
LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders
BEIJING, Feb. 6, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics fo...
2026-02-06 20:00
8834
Cloopen Announces Changes to Board of Directors and Committee Membership
BEIJING, Feb. 5, 2026 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that its Board of Directors (the "Board") has approved resolutions regarding changes to the composition of the Board and the Compensation Committee, effectiveFebruary 5, 2...
2026-02-05 20:00
6709
Goldenstone Acquisition Limited (Ticker: GDST) Announces Intent to Merge with ESG Packaging Innovator Deluxe Technology Group, Targeting 2026 NASDAQ Listing
NEW YORK, TAIPEI, and TOKYO, Feb. 4, 2026 /PRNewswire/ -- Goldenstone Acquisition Limited (Ticker: GDST) ("Goldenstone"), a special purpose acquisition company listed in the U.S. capital market,recently announced the execution of a letter of intent (LOI) for a proposed business combination with ...
2026-02-04 22:00
7000
Nature's Miracle Holding Inc. Appoints Dr. Jinlong "Frank" Du as President of Agricultural Business
ONTARIO, Calif., Feb. 4, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB: NMHI) today announced the appointment ofDr. Jinlong "Frank" Du as President of the Company's Agricultural Business. Dr. Du is a globally recognized entrepreneur and technology leader in indoor growing and contr...
2026-02-04 21:30
6855
CIMG Inc. announced the signing of computing power equipment sales contracts totaling approximately $2 million
HONG KONG, Feb. 3, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance its business partners' sales growth and commercial value, today announced...
2026-02-03 22:20
6912
Locksley Announces High-Grade Antimony Results from Batch Sampling Program at its Mojave Project
SAN BERNARDINO, Calif., Feb. 3, 2026 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQX: LKYRF; OTCQX ADR: LKYLY) announced that a batch sampling program at the DAM antimony (Sb) deposit, part of the Mojave Project in California, returned high grade antimony results. The batch sampling...
2026-02-03 21:42
6135
FiEE, Inc. Provides Select Preliminary Fourth Quarter and Full-Year 2025 Financial Results and Business Update
Strong revenue growth supported by growing customer base and SaaS Solution Business Expected to achieve a positive Net Income highlighting a successful transformation HONG KONG, Feb. 2, 2026 /PRNewswire/ -- FiEE, Inc. (NASDAQ:FIEE) ("FiEE," the "Company," "we," "our," or similar terms), a tech...
2026-02-03 05:15
8731
CreateAI Debuts First Gameplay Trailer for Heroes of Jin Yong, Positioning Wuxia for a Global Audience
SAN DIEGO and BEIJING, Feb. 1, 2026 /PRNewswire/ -- CreateAI (OTC: TSPH) today released the first gameplay trailer forHeroes of Jin Yong, an upcoming 3A open-world role-playing game based on the legendary works ofJin Yong. Featuring real in-game footage, the trailer offers an early look at the ti...
2026-02-01 22:00
8726
Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)
Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression SYDNEY, Jan. 30, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, to...
2026-01-30 21:00
9144
Tantech Holdings Subsidiary, Tanhome Group Inc., Receives Notice of Allowance from USPTO for "TANHOME" Trademark, Fortifying North American Green Building Strategy
LISHUI, China, Jan. 30, 2026 /PRNewswire/ -- Tantech Holdings Ltd. (Nasdaq: TANH) ("Tantech" or the "Company"), today announced that its U.S. subsidiary, Tanhome Group Inc., has received a Notice of Allowance (NOA) from the United States Patent and Trademark Office (USPTO) related to its applicat...
2026-01-30 18:30
8974
Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV), metastatic triple-negative breast cancer (TNBC)....
2026-01-27 21:00
8249
Week's Top Stories
Most Reposted
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 310 media titles]
2026-02-26 09:30
Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 308 media titles]
2026-02-26 19:57
Visa partners with Laufey to spread the magic of travel in Asia Pacific; to be Official Payment Partner for Laufey: A Matter of Time Tour
[Picked up by 307 media titles]
2026-03-04 12:35
SMU and Fudan Launch Region's First Tech-Focused DBA
[Picked up by 300 media titles]
2026-03-02 09:15Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale
[Picked up by 289 media titles]
2026-03-02 09:00
Most Read
COLUMBIA ASIA HOSPITAL BUKIT JALIL LAUNCHES NEW CATH LAB TO STRENGTHEN HEART CARE SERVICES
2026-03-02 14:24
8809
